Medical News

RSS

Novartis receives EC approval for Jakavi to treat myelofibrosis

Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.

28 Aug 2012

Nearly 7% of urologic MDCT scans for hematuria result in incidental findings

A new study from Rhode Island Hospital reports that nearly seven percent of urologic multi-detector computed tomography (MDCT) scans for hematuria result in incidental findings that may be clinically important for the patient. The study is published in the American Journal of Roentgenology.

28 Aug 2012

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Alder Biopharmaceuticals Inc. today announced it has received a $3.5 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2 clinical trial of ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6), in Crohn's disease.

28 Aug 2012

Resverlogix enters $25 million Loan Agreement with Citibank

Resverlogix Corp. today announced that it has entered into a $25 million Loan Agreement with Citibank, N.A.. Resverlogix received the $25 million upon closing of the loan.

28 Aug 2012

Views on abortion debate: Akin's defiance hurts Romney; Sen. Snowe on mending the GOP's image

Rep. Todd Akin doesn't look like he's going away. And that's a problem for Mitt Romney, the presumed Republican nominee. Akin's open defiance makes Romney look like a figurehead. After Romney joined other Republican Party leaders urging Akin to step down as the Republican Senate candidate in Missouri, Akin told the nominee to mind his own business. "Don't you think he may have built this thing up and made a bigger deal about it than he needed to?" Akin said on Sean Hannity's radio show. "Why couldn't he run his race and I'll run mine?"

28 Aug 2012

Reducing TV viewing may effectively prevent excess weight gain among adolescents

Reducing television viewing may be an effective strategy to prevent excess weight gain among adolescents, according to a new study released in the September/October 2012 issue of the Journal of Nutrition Education and Behavior.

28 Aug 2012

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.

28 Aug 2012

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

Morphotek, Inc. announced today that it has commenced a multi-center, Phase II study evaluating the safety and efficacy of MORAb-004 when combined with gemcitabine and docetaxel in the treatment of metastatic soft tissue sarcoma.

28 Aug 2012

Viewpoints: Health law will leave some poor families 'in lurch'; Mich. Gov.'s effort to get health exchange

Confusing language in the health care reform law has raised the possibility that millions of Americans living on modest incomes may be unable to afford their employers' family policies and yet fail to qualify for government subsidies to buy their own insurance. This is a bizarre development that undercuts the basic goal of health care reform - to expand the number of insured people and make their coverage affordable.

28 Aug 2012

Matrix Medical Network announces acquisition of Ascender

Matrix Medical Network, a national leader in prospective medical assessment services, announced today that it has acquired Ascender, a leading provider of integrated, advanced information technology to healthcare clients, in an all-cash transaction.

28 Aug 2012

Leg compressions after stroke appear to trigger natural protective mechanisms that reduce damage

Successive, vigorous bouts of leg compressions following a stroke appear to trigger natural protective mechanisms that reduce damage, researchers report.

28 Aug 2012

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

Depomed, Inc. today announced that Janssen Pharmaceuticals, Inc., has licensed rights to Depomed's Acuform gastric retentive drug delivery technology.

28 Aug 2012

Study explains how breast milk fosters colonies of microbiotic flora in a newborn's intestinal tract

The benefits of breast milk have long been appreciated, but now scientists at Duke University Medical Center have described a unique property that makes mother's milk better than infant formula in protecting infants from infections and illnesses.

28 Aug 2012

FDA approves Gilead’s Stribild to treat HIV-1 infection

The U.S. Food and Drug Administration today approved Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate), a new once-a-day combination pill to treat HIV-1 infection in adults who have never been treated for HIV infection.

28 Aug 2012

America Stem Cell commences ASC-101 Phase I/II study in hematologic malignancies

America Stem Cell, Inc. announced today the initiation of a single-center study at The University of Texas MD Anderson Cancer Center evaluating ASC-101 in dual-umbilical cord transplantation in patients with hematologic malignancies.

28 Aug 2012

Short sleep duration linked to more aggressive breast cancers

Lack of sleep is linked to more aggressive breast cancers, according to new findings published in the August issue of Breast Cancer Research and Treatment by physician-scientists from University Hospitals Case Medical Center's Seidman Cancer Center and Case Comprehensive Cancer Center at Case Western Reserve University.

28 Aug 2012

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

28 Aug 2012

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Neuralstem, Inc. announced the completion of the Phase I trial of its NSI-566 spinal cord neural stem cells for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), with the eighteenth patient treated.

28 Aug 2012

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

The state has eliminated a waiting list for a program that provides lifesaving medications to thousands of low-income, uninsured Georgians with HIV/AIDS more than two years after the list was first started. Established in July 2010, the wait list for Georgia's AIDS Drug Assistance Program rapidly ballooned to more than 1,600 -- at one time becoming the largest in the country. A spike in the need for the program was largely fueled by the economic downturn as people lost their jobs and health insurance.

28 Aug 2012

Chinese Medical Association, Copyright Clearance Center announce agreement

Copyright Clearance Center, Inc. (CCC), a not-for-profit organization and leading provider of licensing solutions, announces an agreement with the Chinese Medical Association (CMA), the largest medical journal publisher in China.

27 Aug 2012

Medical News

Novartis receives EC approval for Jakavi to treat myelofibrosis

Nearly 7% of urologic MDCT scans for hematuria result in incidental findings

Alder’s initiation of ALD518/BMS-945429 Phase 2 trial triggers $3.5M milestone payment

Resverlogix enters $25 million Loan Agreement with Citibank

Views on abortion debate: Akin's defiance hurts Romney; Sen. Snowe on mending the GOP's image

Reducing TV viewing may effectively prevent excess weight gain among adolescents

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Morphotek commences MORAb-004 Phase II metastatic soft tissue sarcoma trial

Viewpoints: Health law will leave some poor families 'in lurch'; Mich. Gov.'s effort to get health exchange

Matrix Medical Network announces acquisition of Ascender

Leg compressions after stroke appear to trigger natural protective mechanisms that reduce damage

Janssen licenses rights to Depomed's Acuform gastric retentive drug delivery technology

Study explains how breast milk fosters colonies of microbiotic flora in a newborn's intestinal tract

FDA approves Gilead’s Stribild to treat HIV-1 infection

America Stem Cell commences ASC-101 Phase I/II study in hematologic malignancies

Short sleep duration linked to more aggressive breast cancers

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Neuralstem completes NSI-566 Phase I trial on amyotrophic lateral sclerosis

Roundup: Ga. AIDS Drug Assistance waiting list at zero; Mass. signs up for health law's disabled adults program

Chinese Medical Association, Copyright Clearance Center announce agreement

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News